Abstract
Pulmonary function and arterial stiffness correlate significantly, attributing to the chronic inflammation of atherosclerosis. However, through the pulmonary or systemic circulation, pulmonary and vascular functions associate hemodynamically with cardiac morphology and function. In the present study, we investigated arterial–cardiac–pulmonary interaction by examining how the pulmonary and vascular functions correlate with the heart. This study investigated 55 consecutive subjects not suffering from pulmonary, vascular and cardiac disease who underwent health screening test at our medical center. First, the presence of atherosclerotic disease (hypertension, dyslipidemia and diabetes) and smoking status of the patients were determined. Next, pulmonary function test, vascular function test including cardio-ankle vascular index, and echocardiography were performed. Then, we examined the correlation among the pulmonary, vascular and the heart. Our results revealed many correlations among these three factors. Especially left atrial dimension (LAD) and E/A ratio (E/A) were important cardiac factors associated with both pulmonary and vascular functions independently. Conventionally, inflammatory responses are known to involve in the correlation between pulmonary and vascular functions. Our study demonstrated that cardiac function and morphology were also involved in this correlation, signifying that LAD and E/A plays important roles in the arterial–cardiac–pulmonary interaction.
Similar content being viewed by others
References
Schroeder EB, Welch VL, Evans GW, Heiss G (2005) Impaired lung function and subclinical atherosclerosis. The ARIC study. Atherosclerosis 180:367–373
Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, Hattori N, Hara H, Kohno N (2009) Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 179:35–40
Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ (2007) Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175(12):1259–1265
Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Ooishi M, Kotani K, Ogawa Y (2008) Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res 31:1921–1930
Masugata H, Senda S, Okada H, Murao K, Inukai M, Himoto T, Hosomi N, Murakami K, Noma T, Kohno M, Goda F (2012) Association between arterial stiffness and pulmonary function in hypertensive patients. Hypertens Res 35:388–392
Noike H, Sugiyama Y, Iizuka T, Shimizu K, Takahashi M, Suzuki M, Hirano K, Mikamo H, Nakagami T, Kiyokawa H, Sato S, Kurosu T, Kawashima T (2013) Association of arteriosclerosis with early chronic obstructive pulmonary disease without respiratory symptoms. J Med Soc Toho 60(5):258–266
Noike H, Nakamura K, Sugiyama Y, Iizuka T, Shimizu Takahashi M, Hirano K, Suzuki M, Mikamo H, Nakagami T, Shirai K (2010) Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb 17:517–525
The Japanese Respiratory Society (2004) Guideline for the diagnosis and treatment of COPD (chronic obstructive pulmonary disease) 2nd edn medical review, Tokyo, pp 1–36
Shirai K, Utino J, Otsuka K, Takata M (2006) A novel blood pressure-independent arterial wall stiffness parameter; cardio ankle vascular index (CAVI). J Atheroscler Thromb 13:101–107
Wallerson DC, Devereux RB (1987) Reproducibility of echocardiographic left ventricular measurements. Hypertension 9(2 Pt 2):II6–II18
Nishimura RA, Appleton CP (1996) ‘Diastology’ beyond E and A. J Am Coll Cardiol 27:372–374
Nishimura RA, Tajik AJ (1997) Evaluation of diastolic filling of left ventricle in health and disease Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 30:8–18
Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. J Cardiol 26:357–366
Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD (2006) C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 61:849–853
Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR (2008) Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 26:26–34
Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetière P (2001) Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med 161:1669–1676
Dohi K, Ito M (2017) The clinical importance of careful and detailed assessment of cardiac function in patients with chronic lung disease. Cardiac Practice 28(1):33–36 (Japanese)
Maclay JD, McAllister DA, Macnee W (2007) Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 12:634–641
Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107:1514–1519
Betge S, Kretzschmar D, Figulla HR, Lichtenauer M, Jung C (2017) Predictive value of the augmentation index derived vascular age in patients with newly diagnosed atherosclerosis. Heart Vessels 32:252–259
Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D (1995) Left atrial size and the risk of stroke and death the Framingham heart study. Circulation 92:835–841
Sato N, Kitagawa I, Okubo S, Masuya H, Tada N, Shinzato R, Takekoshi N (2003) Relationship between insulin resistance and carotid arteriosclerosis, cardiac hypertrophy, and cardiac function in essential hypertensive patients. Jpn J Clin Physiol 33(4):213–217 (Japanese)
Zureik M, Benetos A, Neukirch C, Courbon D, Bean K, Thomas F, Ducimetiere P (2001) Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med 164:2181–2185
Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ (2007) Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175:1259–1265
Abroug F, Ouanes BL (2008) Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Curr Opin Crit Care 14(3):340–347
Akashiba T, Horie K (1993) Cor pulmonare III Topics of pulmonary circulation disorders I. Cor pulmonare and left ventricular function. J Jpn Soc Int Med 82(6):859–862 (Japanese)
Han MK, McLaughlin VV, Criner GJ, Martinez FJ (2007) Pulmonary diseases and the heart. Circulation 116(25):2992–3005
Lee-Chiong TL Jr, Matthay RA (2003) Pulmonary hypertension and cor pulmonale in COPD. Semin Respir Crit Care Med 24(3):263–272
Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk Noordegraaf A, Vachiéry JL (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942–954
Wu TL, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT (2007) A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal 21(6):367–371
Hasegawa A, Matsuda K, Sakuma G, Miyao M, Maezawa H, Nakamoto T (1987) Study of left ventricular function in chronic obstruct heart disease. JJTD 25(Suppl):54 (Japanese)
Saito S, Miyamoto K, Tsujino K, Makita H, Tanino I, Furuya J, Nishimura S, Kawakami Y (1999) Change of left ventricular function and pulmonary circulation in patients of emphysema with time. AJRS 37(Suppl.):241 (Japanese)
Schena M, Clini E, Errera D, Quadri A (1996) Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest 109(6):1446–1451
Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M, Sainty JM, Jean OJ (2000) Left atrial and ventricular filling in chronic obstructive pulmonary disease: an echocardiographic and doppler study. Am J Respir Crit Care Med 162(2 Pt 1):670–675
Ciobanu A, Dulgheru R, Dragoi R, Magda S, Florescu M, Mihaila S, Rimbas RC, Cinteza M, Vinereanu D (2011) P268 Best determinants of left atrial function are left ventricular longitudinal systolic function and arterial stiffness. Eur J Echocardiogr 12(Suppl. 2):ii14–ii44
Cichoń M, Wieczorek J, Wybraniec M, Woźniak-Skowerska I, Hoffmann A, Nowak S, Szydło K, Wnuk-Wojnar A, Mizia-Stec K (2019) Left atrial function in obese and non-obese patients undergoing percutaneous pulmonary vein isolation. Heart Vessels 34:343–351
Starling MR (1993) Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 125:1659–1666
Kass DA (2002) Age-related changes in ventricular-arterial coupling: pathophysiologic implications. Heart Fail Rev 7:51–62
Sakane K, Miyoshi T, Doi M, Hirohata S, Kaji Y, Kamikawa S, Ogawa H, Hatanaka K, Kitawaki T, Kusachi S, Yamamoto K (2008) Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. J Atheroscler Thromb 15(5):261–268
Ishitake H, Sakura E, Sasaki H, Nakamura F, Okamoto M (1993) Left ventricular diastolic filling characteristics in relation to the stage of essential hypertension. Jpn J Med Ultrason 20(2):77–85
Tabako S, Harada M, Miyasaka T, Yoshikawa K, Takarada Y, Masuya N, Hayashi K, Hara F (2011) Evaluation of left ventricular diastolic function according to the generation in patients with hypertension using left atrial volume index. Jpn J Med Ultrason 38(4):447–454 (Japanese)
Simek CL, Feldman MD, Haber HL, Wu CC, Jayaweera AR, Kaul S (1995) Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr 8:37–47
Ganau A, Devereux RB, Roman MJ, De Simone GS, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cordial 19:1550–1558
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Inoue, Y., Adachi, M. & Maruyama, Y. Investigation of arterial–cardiac–pulmonary interaction. Heart Vessels 34, 1325–1331 (2019). https://doi.org/10.1007/s00380-019-01362-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-019-01362-9